Tatsuhiko Urakami1, Remi Kuwabara2, Kei Yoshida2. 1. Department of Pediatrics, Nihon University School of Medicine, 1-6 Kandasurugadai, Chiyoda-ku, Tokyo, Japan. urakami.tatsuhiko@nihon-u.ac.jp. 2. Department of Pediatrics, Nihon University School of Medicine, 1-6 Kandasurugadai, Chiyoda-ku, Tokyo, Japan.
Abstract
PURPOSE OF REVIEW: The economic burden of diabetes in Japan is already serious and will become greater in the future. We review the economic impact of diabetes in Japan to examine viable options for mitigating its effects. RECENT FINDINGS: Medical costs for diabetes have been increasing by US $1 million annually, reaching US $11 million in 2009, of which US $7 million was accounted for by people aged 65 years or older. The quality of treatment of diabetes in Japan is higher than in other regions in the world. This can be more effective for achieving glycemic control, but is also more expensive compared with conventional treatment. Because of the high cost of diabetes in Japan, a coordinated response is needed. Intervention trials for people with prediabetes aimed at preventing the occurrence of diabetes seem to be the most cost-effective method for lowering the medical costs of diabetes, rather than the use of new, expensive antidiabetic drugs in patients with established diabetes.
PURPOSE OF REVIEW: The economic burden of diabetes in Japan is already serious and will become greater in the future. We review the economic impact of diabetes in Japan to examine viable options for mitigating its effects. RECENT FINDINGS: Medical costs for diabetes have been increasing by US $1 million annually, reaching US $11 million in 2009, of which US $7 million was accounted for by people aged 65 years or older. The quality of treatment of diabetes in Japan is higher than in other regions in the world. This can be more effective for achieving glycemic control, but is also more expensive compared with conventional treatment. Because of the high cost of diabetes in Japan, a coordinated response is needed. Intervention trials for people with prediabetes aimed at preventing the occurrence of diabetes seem to be the most cost-effective method for lowering the medical costs of diabetes, rather than the use of new, expensive antidiabetic drugs in patients with established diabetes.
Entities:
Keywords:
Diabetes; Economic impact; Intervention trial; Japan; Medical cost
Authors: Christian Bommer; Esther Heesemann; Vera Sagalova; Jennifer Manne-Goehler; Rifat Atun; Till Bärnighausen; Sebastian Vollmer Journal: Lancet Diabetes Endocrinol Date: 2017-04-26 Impact factor: 32.069
Authors: Christian Bommer; Vera Sagalova; Esther Heesemann; Jennifer Manne-Goehler; Rifat Atun; Till Bärnighausen; Justine Davies; Sebastian Vollmer Journal: Diabetes Care Date: 2018-02-23 Impact factor: 19.112